> 资讯    /    正文

Webtel.mobi prepares to recommence global operations. Starts media campaign with Oasis Tickets Compe

Image of WM’s impending upgraded UI

Image of WM's impending upgraded UI

LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- After completing the upgrade of its AI-Powered “All Transactions” Facilities, Global Specialized Mobile Provider Webtel.mobi (“WM”) is starting its media campaign while it completes its final UI improvement.

WM is kicking off its media campaign by running three competitions for entrants to win pairs of tickets to the final Oasis Concert at London's Wembley Stadium on the 28th of September 2025.

Hosted on the established Competitions platform Raffall, the three Oasis ticket competitions are for a Diamond Hospitality pair of tickets, and two Standing pairs of tickets, at the sold-out final performance.

The decision to have the Competitions hosted on Raffall was to keep an arms-length between WM and the professional tasks of Competition hosting, draws and winner-selection. WM's view was that these aspects were best managed by a reputable sector expert entity in those fields, on its reliable platform.

WM's UI upgrade – designed to better suit a retail market as opposed to its specialized entities market – is scheduled to complete in October, at which time it will recommence its “All Transactions” activities worldwide, from its unitary global platform.

The Oasis competitions are running on the Raffall platform from 01 September, with the winners' draws taking place on 25 September 2025.

Webtel.mobi:
https://webtel.mobi

Contact:
competitions@webtel.mobi

Competition details:

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e2d7a09-c01e-4ce1-a40d-e5e98f7fd7fd

最新文章

Webtel.mobi prepares to recommence global operations. Starts media campaign with Oasis Tickets Compe Webtel.mobi prepares to recommence global operations. Starts media campaign with Oasis Tickets Compe 别把药食同源吃成政策困境下的智商税!知医邦用“AI辨体”破局 袁铭:以武铸魂,照亮海派武脉传承之路 Polpharma Biologics与MS Pharma就维多珠单抗(PB016)、奥瑞珠单抗(PB018)和古塞库单抗(PB019)候选生物类似药签署许可协议 Amazon在新西兰推出基础设施区域

Copyright © 2024 商圈 All Rights Reserved.

本站部分内容来源于用户投稿,内容相关Q:230098551